{"id":55354,"date":"2023-03-30T14:05:52","date_gmt":"2023-03-30T12:05:52","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\/"},"modified":"2023-03-30T14:05:52","modified_gmt":"2023-03-30T12:05:52","slug":"northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\/","title":{"rendered":"NorthStar Medical Radioisotopes Announces Presentations at Upcoming Jefferies Radiopharma Innovation Summit"},"content":{"rendered":"
\n

BELOIT, Wis.–(BUSINESS WIRE)–NorthStar Medical Radioisotopes<\/a>, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic and medical imaging applications, today announced that it will be presenting at the upcoming Jefferies Radiopharma Innovation Summit. The event will be held in New York, NY, on April 3, 2023. Stephen Merrick, Chief Executive Officer of NorthStar, will present an overview of the Company from 8:00 a.m. – 8:30 a.m. ET, and participate in a panel discussion, \u201cDeep Dive into Production of Alpha Emitters: Current and Future Directions,\u201d from 12:15 – 1:00 p.m. ET.\n<\/p>\n

<\/a><\/p>\n

\n\u201cNorthStar continues to expand our leadership position in the rapidly growing area of therapeutic and diagnostic radioisotopes, radiopharmaceuticals, and radiopharmaceutical contract development manufacturing organization (CDMO\/CMO) services,\u201d said Stephen Merrick, President and Chief Executive Officer of NorthStar Medical Radioisotopes. \u201cOur company is poised to be the first commercial-scale producer of therapeutic radioisotopes copper-67 and non-carrier added (n.c.a.) actinium-225, and we are strongly positioned for continued rapid growth. We look forward to sharing information about our innovative and environmentally sustainable approach to radioisotope production with the investor community at this important Jefferies conference.\u201d\n<\/p>\n

\nAbout NorthStar Medical Radioisotopes, LLC<\/b>\n<\/p>\n

\nNorthStar Medical Radioisotopes is a commercial-stage nuclear medicine company focused on advancing patient care by providing diagnostic and therapeutic radioisotopes, novel radiopharmaceuticals and customized radiopharmaceutical development services. Its proven management team and state-of-the-art, environmentally preferable and non-uranium based technologies have made it an emerging leader at the forefront of U.S. medical radioisotope and radiopharmaceutical production. NorthStar\u2019s molybdenum-99 (Mo-99) program is the sole source of domestic Mo-99, used to generate the standard-of-care diagnostic imaging radioisotope for assessing heart disease and cancer. It is expanding its industry-leading position in the growing area of therapeutic radioisotopes, used in targeted radiopharmaceutical therapy to treat cancer and other serious diseases, and is poised to be the first commercial-scale producer of non-carrier added (n.c.a.) actinium-225 (Ac-225) and copper-67 (Cu-67). NorthStar\u2019s Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO\/CMO) services unit will provide customized service offerings and specialized radiopharmaceutical expertise to help biopharmaceutical companies rapidly advance their development and commercialization programs. For more information about NorthStar\u2019s comprehensive portfolio and patient-focused services, visit: www.northstarnm.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor NorthStar Medical Radioisotopes, LLC<\/b>
Corporate:
\n
Lisa Holst
\n
Vice President Sales and Marketing
\n
678-471-9027
\n
lholst@northstarnm.com<\/a><\/p>\n

Investor Relations:
\n
Paul Estrem
\n
Executive Vice President and Chief Financial Officer
\n
608-987-8318
\n
pestrem@northstarnm.com<\/a><\/p>\n

Media:
\n
Priscilla Harlan
\n
781-799-7917
\n
pharlan@shiningrockllc.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

BELOIT, Wis.–(BUSINESS WIRE)–NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic and medical imaging applications, today announced that it will be presenting at the upcoming Jefferies Radiopharma Innovation Summit. The event will be held in New York, NY, on April 3, 2023. Stephen Merrick, Chief Executive … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55354","6":"format-standard","7":"category-industry"},"yoast_head":"\nNorthStar Medical Radioisotopes Announces Presentations at Upcoming Jefferies Radiopharma Innovation Summit - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NorthStar Medical Radioisotopes Announces Presentations at Upcoming Jefferies Radiopharma Innovation Summit - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"BELOIT, Wis.–(BUSINESS WIRE)–NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic and medical imaging applications, today announced that it will be presenting at the upcoming Jefferies Radiopharma Innovation Summit. The event will be held in New York, NY, on April 3, 2023. Stephen Merrick, Chief Executive ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-30T12:05:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230330005031\/en\/727032\/21\/NorthStar_Medical_Radioiostopes_LLC_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"NorthStar Medical Radioisotopes Announces Presentations at Upcoming Jefferies Radiopharma Innovation Summit\",\"datePublished\":\"2023-03-30T12:05:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\\\/\"},\"wordCount\":422,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230330005031\\\/en\\\/727032\\\/21\\\/NorthStar_Medical_Radioiostopes_LLC_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\\\/\",\"name\":\"NorthStar Medical Radioisotopes Announces Presentations at Upcoming Jefferies Radiopharma Innovation Summit - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230330005031\\\/en\\\/727032\\\/21\\\/NorthStar_Medical_Radioiostopes_LLC_logo.jpg\",\"datePublished\":\"2023-03-30T12:05:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230330005031\\\/en\\\/727032\\\/21\\\/NorthStar_Medical_Radioiostopes_LLC_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230330005031\\\/en\\\/727032\\\/21\\\/NorthStar_Medical_Radioiostopes_LLC_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NorthStar Medical Radioisotopes Announces Presentations at Upcoming Jefferies Radiopharma Innovation Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NorthStar Medical Radioisotopes Announces Presentations at Upcoming Jefferies Radiopharma Innovation Summit - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\/","og_locale":"en_US","og_type":"article","og_title":"NorthStar Medical Radioisotopes Announces Presentations at Upcoming Jefferies Radiopharma Innovation Summit - Pharma Trend","og_description":"BELOIT, Wis.–(BUSINESS WIRE)–NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic and medical imaging applications, today announced that it will be presenting at the upcoming Jefferies Radiopharma Innovation Summit. The event will be held in New York, NY, on April 3, 2023. Stephen Merrick, Chief Executive ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-30T12:05:52+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230330005031\/en\/727032\/21\/NorthStar_Medical_Radioiostopes_LLC_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"NorthStar Medical Radioisotopes Announces Presentations at Upcoming Jefferies Radiopharma Innovation Summit","datePublished":"2023-03-30T12:05:52+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\/"},"wordCount":422,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230330005031\/en\/727032\/21\/NorthStar_Medical_Radioiostopes_LLC_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\/","url":"https:\/\/pharma-trend.com\/en\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\/","name":"NorthStar Medical Radioisotopes Announces Presentations at Upcoming Jefferies Radiopharma Innovation Summit - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230330005031\/en\/727032\/21\/NorthStar_Medical_Radioiostopes_LLC_logo.jpg","datePublished":"2023-03-30T12:05:52+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230330005031\/en\/727032\/21\/NorthStar_Medical_Radioiostopes_LLC_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230330005031\/en\/727032\/21\/NorthStar_Medical_Radioiostopes_LLC_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/northstar-medical-radioisotopes-announces-presentations-at-upcoming-jefferies-radiopharma-innovation-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"NorthStar Medical Radioisotopes Announces Presentations at Upcoming Jefferies Radiopharma Innovation Summit"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55354","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55354"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55354\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55354"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55354"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55354"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}